RELMADA THERAPEUTICS, INC. Derivative Liability, Current
RELMADA THERAPEUTICS, INC. (RLMD) had Derivative Liability, Current of $4.51 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2020-03-26
- 2018-09-30: Derivative Liability, Current $4.51M.
- 2018-06-30: Derivative Liability, Current $4.19M.
- 2018-03-31: Derivative Liability, Current $3.96M.
- 2017-12-31: Derivative Liability, Current $3.68M.
| Period end | Derivative Liability, Current |
|---|---|
| 2018-09-30 | $4.51M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $4.19M 10-KT · filed 2020-03-26 |
| 2018-03-31 | $3.96M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $3.68M 10-Q · filed 2018-02-12 |
| 2017-09-30 | $2.52M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $175.85K 10-K · filed 2018-09-28 |
| 2017-03-31 | $279.43K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $523.50K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $972.55K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $892.50K 10-K · filed 2017-09-28 |
| 2016-03-31 | $614.08K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.45M 10-Q · filed 2016-02-05 |
| 2015-09-30 | $4.71M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $14.00M 10-K · filed 2016-09-09 |
| 2015-03-31 | $24.47M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $26.57M 10-Q · filed 2015-02-13 |
| 2014-09-30 | $46.82M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $25.59M 10-K · filed 2015-09-11 |
| 2014-03-31 | $12.77M 8-K · filed 2014-05-27 |
| 2013-12-31 | $20.10M 10-K · filed 2015-09-11 |
| 2012-12-31 | $5.09M 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |